A prodrug form of fosinoprilat
Related Products
Labeled Version(s)
31917Fosinopril-d7 (sodium salt)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Fosinopril (sodium salt)

Item No. 21899

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
4S-cyclohexyl-1-[2-[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-L-proline, monosodium salt
CAS Number
88889-14-9
Synonyms
  • SQ 28,555
Molecular Formula
C30H45NO7P • Na
Formula Weight
585.6
Purity
≥98%
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
Methanol: 1 mg/ml
SMILES
O=C(N1[C@H](C([O-])=O)C[C@@H](C2CCCCC2)C1)CP(CCCCC3=CC=CC=C3)(O[C@H](OC(CC)=O)C(C)C)=O.[Na+]
InChi Code
InChI=1S/C30H46NO7P.Na/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24;/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35);/q;+1/p-1/t25-,26+,30+,39?;/m1./s1
InChi Key
TVTJZMHAIQQZTL-TXDYNIFHSA-M
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    10 mg

    $41

    Add

    25 mg

    $85

    Add

    50 mg

    $152

    Add

    100 mg

    $272

    Add
    Product Description

    Fosinopril is a prodrug form of the angiotensin converting enzyme (ACE) inhibitor fosinoprilat.1 Oral administration of fosinopril inhibits angiotensin I-induced pressor responses in normotensive rats, dogs, and monkeys when administered at doses of 15, 15, and 10 µmol/kg, respectively. Fosinopril (2.5 mg/kg) reduces fractional shortening and decreases left ventricular size in a porcine model of congestive heart failure.2 Formulations containing fosinopril have been used in the treatment of hypertension and congestive heart failure.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. DeForrest, J.M., Waldron, T.L., Harvey, C., et al. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: In vitro and preclinical in vivo pharmacology. J. Cardiovasc. Pharmacol. 14(5), 730-736 (1989).

    2. McElmurray, J.H., III, Mukherjee, R., New, R.B., et al. Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: Comparative effects on left ventricular function and geometry. J. Pharmacol. Exp. Ther. 291(2), 799-811 (1999).